Skip to main content
Skip to footer
About
Active Biotech in Brief
Management
Board of Directors
Goals and Strategy
Corporate Governance
Corporate Governance Report 2025
Article of Association
General Meetings
Audit committee
Scientific committee
Election Committee
Auditors
Projects
Our projects
Tasquinimod
Laquinimod
Naptumomab
Patents
Clinical Studies
Investor
Overview
Analyses and Presentations
Financial Calendar
Financial Reports
Shareholders
Events
Rights Issues
Rights Issue 2025
Media
Overview
Press Contact
Press Releases
Contact
Svenska
Financial Calendar
Investor
2026
20
Aug
Interim Report Jan-Jun 2026
2026
05
Nov
Interim Report Jan-Sep 2026
2027
11
Feb
Year-end Report 2026
2027
06
May
Interim Report Jan-Mar 2027
2027
20
May
Annual General Meeting 2027
2027
19
Aug
Interim Report Jan-Jun 2027
2027
04
Nov
Interim Report Jan-Sep 2027
